中华胸心血管外科杂志
中華胸心血管外科雜誌
중화흉심혈관외과잡지
Chinese Journal of Thoracic and Cardiovascular Surgery
2012年
11期
670-673
,共4页
胡行健%史嘉玮%刘金平%卢晓芳%袁锋%邓诚%史峰%董念国
鬍行健%史嘉瑋%劉金平%盧曉芳%袁鋒%鄧誠%史峰%董唸國
호행건%사가위%류금평%로효방%원봉%산성%사봉%동념국
心脏瓣膜假体置入%模型,动物%原位%异位%微创
心髒瓣膜假體置入%模型,動物%原位%異位%微創
심장판막가체치입%모형,동물%원위%이위%미창
Valve implantation%Model,animal%Orthotropic%Heterotrophic%Minimally invasive
目的 构建微创大动物瓣膜置入模型,评价其效果.方法 应用枝化状聚乙二醇交联猪去细胞主动脉瓣构建新型组织工程化瓣膜替代物,参照Corevalve经导管瓣膜置入系统,自制微创瓣膜释放系统.成年雄性山羊18只,分为原位超声引导组(A组)、原位X线造影引导组(B组)和异位直接释放组(C组),每组6只,全麻下借助心脏超声和X线造影引导,于主动脉瓣原位或胸降主动脉异位行微创瓣膜置入.术后4周时行心脏CT和超声以评价瓣膜近期功能.结果 手术成功率分别为A组66.7%(4/6只)、B组50.0%(3/6只)和C组100.0%(6/6只),多重x2比较提示A、B组间差异无统计学意义,但与C组间差异均有统计学意义.3组分别手术(79±18) min、(61 ±23) min和(45±15) min,单向方差分析提示组间差异有统计学意义.术后4周存活率分别为100%(4/4只)、100%(3/3只)和83.3%(5/6只),多重x2比较提示组间差异无统计学意义.心脏CT和超声证实术后即刻和4周时,原位置入的瓣膜定位稳定,瓣叶开合良好,无狭窄及反流.结论 3组瓣膜置入羊模型均无需体外循环辅助,并具有创伤小、无需输血、可重复性较好等优点,近期存活率满意.A组技术设备简单,但超声定位精确性有限,操作时间较长;B组定位准确迅速,但依赖X线造影设备;C组手术成功率高,但置入的瓣叶无功能性启闭活动,仅适用于瓣膜生物相容性的在体观察.
目的 構建微創大動物瓣膜置入模型,評價其效果.方法 應用枝化狀聚乙二醇交聯豬去細胞主動脈瓣構建新型組織工程化瓣膜替代物,參照Corevalve經導管瓣膜置入繫統,自製微創瓣膜釋放繫統.成年雄性山羊18隻,分為原位超聲引導組(A組)、原位X線造影引導組(B組)和異位直接釋放組(C組),每組6隻,全痳下藉助心髒超聲和X線造影引導,于主動脈瓣原位或胸降主動脈異位行微創瓣膜置入.術後4週時行心髒CT和超聲以評價瓣膜近期功能.結果 手術成功率分彆為A組66.7%(4/6隻)、B組50.0%(3/6隻)和C組100.0%(6/6隻),多重x2比較提示A、B組間差異無統計學意義,但與C組間差異均有統計學意義.3組分彆手術(79±18) min、(61 ±23) min和(45±15) min,單嚮方差分析提示組間差異有統計學意義.術後4週存活率分彆為100%(4/4隻)、100%(3/3隻)和83.3%(5/6隻),多重x2比較提示組間差異無統計學意義.心髒CT和超聲證實術後即刻和4週時,原位置入的瓣膜定位穩定,瓣葉開閤良好,無狹窄及反流.結論 3組瓣膜置入羊模型均無需體外循環輔助,併具有創傷小、無需輸血、可重複性較好等優點,近期存活率滿意.A組技術設備簡單,但超聲定位精確性有限,操作時間較長;B組定位準確迅速,但依賴X線造影設備;C組手術成功率高,但置入的瓣葉無功能性啟閉活動,僅適用于瓣膜生物相容性的在體觀察.
목적 구건미창대동물판막치입모형,평개기효과.방법 응용지화상취을이순교련저거세포주동맥판구건신형조직공정화판막체대물,삼조Corevalve경도관판막치입계통,자제미창판막석방계통.성년웅성산양18지,분위원위초성인도조(A조)、원위X선조영인도조(B조)화이위직접석방조(C조),매조6지,전마하차조심장초성화X선조영인도,우주동맥판원위혹흉강주동맥이위행미창판막치입.술후4주시행심장CT화초성이평개판막근기공능.결과 수술성공솔분별위A조66.7%(4/6지)、B조50.0%(3/6지)화C조100.0%(6/6지),다중x2비교제시A、B조간차이무통계학의의,단여C조간차이균유통계학의의.3조분별수술(79±18) min、(61 ±23) min화(45±15) min,단향방차분석제시조간차이유통계학의의.술후4주존활솔분별위100%(4/4지)、100%(3/3지)화83.3%(5/6지),다중x2비교제시조간차이무통계학의의.심장CT화초성증실술후즉각화4주시,원위치입적판막정위은정,판협개합량호,무협착급반류.결론 3조판막치입양모형균무수체외순배보조,병구유창상소、무수수혈、가중복성교호등우점,근기존활솔만의.A조기술설비간단,단초성정위정학성유한,조작시간교장;B조정위준학신속,단의뢰X선조영설비;C조수술성공솔고,단치입적판협무공능성계폐활동,부괄용우판막생물상용성적재체관찰.
Objective To establish and evaluate 3 kinds of minimally-invasive valve implantation model in vivo.Methods A novel tissue engineered heart valve(TEHV) manufactured by branched polyethylene glycol cross-linked acellular porcine valve and a minimally-invasive valve implantation system according to the design of Corevalve revalving system were adopted.After anesthesia,18 adult male goats were randomly divided into 3 groups: the ulrasound-directed orthotropic group (group A,n =6),angiography-directed orthotropic group (group B,n =6) and direct-released heterotopic group (group C,n =6),and all received minimally-invasive valve implantation orthotropically or heterotopically.4 weeks later,the valvular function was evaluated by CTA and/or echocardiography.Results All 3 kinds of caprine model were successfully constructed.The operation success rate of each group was A: 66.7%,B: 50.0% and C: 100.0%,respectively(multiple x2 analysis,group A and B P >0.05; group A and C,group B and C,P <0.05).The operation-time of each group was A: (79 ± 18) min,B:(61 ±23) min,C: (45 ± 15) min(one-way ANOVA,P <0.05).The survival rate at4 weeks was A: 100%,B: 100% and C: 83.3% (multiple x2 analysis,P > 0.05).Echocardiography and CTA proved the short-term function of implanted TEHV was satisfactory.Conclusion All 3 kinds of caprine valve implantation model can be established without cardiopulmonary bypass and blood transfusion.The devices and equipments required in group A is relatively simple,but the procedure cost longer time for it is hard to determine the right position by ultrasound.The application of angiography made the positioning much easier in group B while the procedure had to be performed in specific operation room with angiographic apparatus.Group C did rely on neither special equipments nor complex operation,but the valve leaflets cannot work normally,so this model was only suitable for testing in vivo characteristics such as biocompatiblities.